大剂量盐酸氨溴索防治新生儿呼吸窘迫综合征的临床观察

大剂量盐酸氨溴索防治新生儿呼吸窘迫综合征的临床观察
梁静玲;曹虹;周锦妍;李克蓉
【期刊名称】《昆明医科大学学报》
【年(卷),期】2011(032)007
【摘要】Objective To investigate the clinical efficacy and safety of ambroxol hydrochloride in preventing and treating neonatal respiratory distress syndrome (NRDS). Methods 91 premature infants were divided into two groups randomly. 45 premature infants in control group were preformed with combined therapy. On this basis, 46 cases in treatment group were given ambroxol hydrochloride, 7.5 mg/kgt intervenous drop infusion, once every six hours, the course of treatment was 7 days. Results The incidence of NRDS in the treatment group was lower than that in the control group (15% vs 40% ). The respiratory distress relief time, oxygen time and the lengths of hospitalization in the treatment group were shorter than those in the control group C(77.6±9.1) hvs (83.3
±10.5) h; (69.2±7.6) h vs (74.2 ±8.9) h; (12.5 ±2.9) d vs (14.7 ±3.4) d, respectively] , there was a significant difference (P<0.0l). Conclusion Ambroxol hydrochloride has significant clinical effects in prevention and treatment of NRDS, and deserves to generalize in clinic.%目的探讨大剂量
盐酸氨溴索防治新生儿呼吸窘迫综合征(NRDS)的临床效果及安全性.方法 91例早
产儿被随机分为两组,对照组45例给予综合治疗；治疗组46例在此基础上给予盐
酸氨溴索,7.5mg/kg,静脉注射,次/6h,连用7d.结果治疗组患儿NRDS的发生率较
对照组低(15%与40%),呼吸窘迫消失的时间[(77.6±9.1)h与(83.3±10.5)h]、氧疗时间[(69.2±7.6)h与(74.2±8.9)h]及住院时间[(12.5±2.9)d与(14.7±3.4)d]明显较对照组短,且差异均有统计学意义(P＜0.01).结论盐酸氨溴索对预防和治疗NRDS 有明显的临床效果,值得临床推广应用.
【总页数】4页(P120-123)
【作者】梁静玲;曹虹;周锦妍;李克蓉
【作者单位】昆明市延安医院儿科,云南昆明650051;昆明市延安医院儿科,云南昆明650051;昆明市延安医院儿科,云南昆明650051;昆明市延安医院儿科,云南昆明650051
【正文语种】中文
【中图分类】R722.12
【相关文献】
1.大剂量盐酸氨溴索防治新生儿呼吸窘迫综合征的疗效观察 [J], 朱峰;黄启凌
2.大剂量盐酸氨溴索联合新型鼻罩持续呼吸道正压通气治疗新生儿呼吸窘迫综合征[J], 林明祥;李玩如;潘海贤;林荣华;赵奕怀
3.盐酸氨溴索治疗新生儿呼吸窘迫综合征100例临床观察 [J], 宿晓东
4.大剂量盐酸氨溴索配合持续气道正压治疗新生儿呼吸窘迫综合征的临床观察 [J], 罗显荣;李相美;张燕;张静;何刚
5.鼻塞/鼻罩持续气道正压通气联合大剂量盐酸氨溴索治疗新生儿呼吸窘迫综合征的效果探讨 [J], 平菊梅
因版权原因，仅展示原文概要，查看原文内容请购买。